MedTrace Logo

HCC Risk Prediction Model Based on Multimodal Data in Chronic Hepatitis B

NCT07780357 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2026-08-28

No results posted yet for this study

Summary

The investigators propose to construct and validate an early HCC risk prediction model in a multicenter retrospective cohort of hepatitis B-related fibrosis/cirrhosis patients, using multimodal data encompassing longitudinal clinical data, serum glycomics profiles, and liver biopsy histopathological images.

Conditions

  • Hepatocellular Carcinoma (HCC)

Interventions

OTHER

No intervention (observational study)

No intervention (observational study)

Sponsors & Collaborators

  • The Second Hospital & Clinical Medical School, Lanzhou University

    collaborator UNKNOWN

  • Beijing Ditan Hospital

    collaborator OTHER

  • Yuncheng Central Hospital

    collaborator OTHER

  • Guangzhou Eighth People's Hospital, Guangzhou Medical University.

    collaborator UNKNOWN

  • Beijing Friendship Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-20
Primary Completion
2027-08-31
Completion
2028-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07780357 on ClinicalTrials.gov